2-ethylphenyl phosphonic acid monoethyl ester | 881923-50-8

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 英文名称: 2-ethylphenyl phosphonic acid monoethyl ester
• 英文别名: Ethoxy-(2-ethylphenyl)phosphinic acid
• CAS: 881923-50-8
• 化学式: C₁₀H₁₅O₃P
• 分子量: 214.201
• InChiKey: FJDGYKBSRZVREY-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  1.7
• 重原子数：
  14
• 可旋转键数：
  4
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.4
• 拓扑面积：
  46.5
• 氢给体数：
  1
• 氢受体数：
  3

反应信息

• 作为反应物：
  描述：

  2-ethylphenyl phosphonic acid monoethyl ester 、 丙烯酸甲酯（MA） 在 disodium hydrogenphosphate 、 dichloro(pentamethylcyclopentadienyl)rhodium (III) dimer 、 silver(I) acetate 作用下， 以 乙腈 为溶剂， 反应 16.0h， 以89%的产率得到methyl 2-(1-ethoxy-7-ethyl-1,3-dihydrobenzo[c][1,2]oxaphosphol-3-yl-1-oxide)acetate
  参考文献：
  名称：

  芳基膦酸单乙基酯与烯烃的铑催化氧化环化反应：苯并恶唑磷1-氧化物的高效合成

  摘要：

  在有氧条件下，使用芳基膦酸单乙酯和烯烃开发了铑催化的串联氧化烯基化反应和分子内的氧-迈克尔反应，从而以良好的收率获得了良好的苯并恶唑1-氧化物。

  DOI：

  10.1021/ol401775t

文献信息

• Phosphaannulation of Aryl- and Benzylphosphonic Acids with Unactivated Alkenes<i>via</i>Palladium-Catalyzed CH Activation/Oxidative Cyclization Reaction
  作者：Woo Hyung Jeon、Jeong-Yu Son、Sun-Eung Kim、Phil Ho Lee

  DOI：10.1002/adsc.201400793

  日期：2015.3.9

  An efficient phosphaannulation via palladium(II)‐catalyzed CH activation/oxidative cyclization by the 6‐endo mode is reported for the synthesis of 3‐substituted phosphaisocoumarins from the reaction of arylphosphonic acids with unactivated alkenes under aerobic conditions. Also, α,α‐disubstituted benzylphosphonic acids were phosphaannulated with unactivated alkenes, producing phosphaisochromanones

  一种高效phosphaannulation经由钯（II） -催化Ç  ħ活化/氧化环化由6-内切模式报道了3-取代phosphaisocoumarins的从芳基膦酸与需氧条件下未活化的链烯烃反应合成。同样，将α，α-二取代的苄基膦酸与未活化的烯烃进行磷环化，通过6- exo模式通过抗-磷酰氧基palpalation生成具有（Z）-亚烷基的磷异色酮。
• Synthesis of Dihydrophosphaisocoumarins through a Palladium-Catalyzed Oxidative Cyclization of Arylphosphonic Acid Monoethyl Esters with 1,3-Dienes
  作者：Jeong-Yu Son、Hyunseok Kim、Woo Hyung Jeon、Yonghyeon Baek、Boram Seo、Kyusik Um、Kooyeon Lee、Phil Ho Lee

  DOI：10.1002/adsc.201700742

  日期：2017.9.18

  ins and their derivatives was developed through a palladium-catalyzed oxidative cyclization reaction of a wide range of arylphosphonic acid monoethyl esters with activated and unactivated 1,3-dienes, including 1-aryl-substituted 1,3-dienes and 1-alkyl-substituted 1,3-dienes, thus opening a new avenue for the synthesis of phosphaheterocyclic compounds.

  通过广泛的芳基膦酸单乙基酯与活化和未活化的1,3-二烯（包括1-芳基取代的1， 3-二烯和1-烷基取代的1，3-二烯，从而为合成磷杂环化合物开辟了一条新途径。
• PHOSPHO-INDOLES AS HIV INHIBITORS
  申请人：Storer Richard

  公开号：US20090163444A1

  公开（公告）日：2009-06-25

  3-phosphoindole compounds for the treatment of retroviral infections, and particularly for HIV, are described. Also included are compositions comprising the 3-phosphoindole derivatives alone or in combination with one or more other anti-retroviral agents, processes for their preparation, and methods of manufacturing a medicament incorporating these compounds.

  本文介绍了用于治疗逆转录病毒感染，尤其是HIV的3-磷酸吲哚化合物。还包括仅由3-磷酸吲哚衍生物或与一种或多种其他抗逆转录病毒药物组合而成的组合物，其制备过程以及制造包含这些化合物的药物的方法。
• Phosphoindoles as HIV inhibitors
  申请人：IDENIX Pharmaceuticals, Inc.

  公开号：EP1961757A1

  公开（公告）日：2008-08-27

  3-phosphoindole compounds for the treatment of retroviral infections, and particularly for HIV, are described. Also included are compositions comprising the 3-phosphoindole derivatives alone or in combination with one or more other anti-retroviral agents, processes for their preparation, and methods of manufacturing a medicament incorporating these compounds.

  本文描述了用于治疗逆转录病毒感染，特别是艾滋病毒的 3-膦酰吲哚化合物。此外，还包括由 3-膦酰吲哚衍生物单独或与一种或多种其他抗逆转录病毒药物组合而成的组合物、其制备工艺以及制造含有这些化合物的药物的方法。
• Phospho-indoles as HIV inhibitors
  申请人：IDENIX Pharmaceuticals, Inc.

  公开号：EP2256124A1

  公开（公告）日：2010-12-01

  3-Phosphoindonle compounds for the treatment of retroviral infections, and particularly for HIV, are described. Also included are compositions comprising the 3-phosphoindole derivatives alone or in combination with one or more other anti-retroviral agents, processes for their preparation, and methods of manufacturing a medicament incorporating these compounds.

  本文描述了用于治疗逆转录病毒感染，特别是艾滋病毒的 3-磷吲哚化合物。此外，还包括由 3-磷吲哚衍生物单独或与一种或多种其他抗逆转录病毒药物组合而成的组合物、其制备工艺以及生产含有这些化合物的药物的方法。